| 000 | 01473 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512135953.0 | ||
| 264 | 0 | _c19710607 | |
| 008 | 197106s 0 0 eng d | ||
| 022 | _a0003-6919 | ||
| 024 | 7 |
_a10.1128/am.21.3.426-434.1971 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWick, W E | |
| 245 | 0 | 0 |
_aCephaloglycin and its biologically active metabolite desacetylcephaloglycin. _h[electronic resource] |
| 260 |
_bApplied microbiology _cMar 1971 |
||
| 300 |
_a426-34 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacillus subtilis _xdrug effects |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 | _aBiological Assay |
| 650 | 0 | 4 |
_aCephalosporins _xadministration & dosage |
| 650 | 0 | 4 | _aChromatography, Paper |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHuman Experimentation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aSarcina _xdrug effects |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aTemperature |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xdrug therapy |
| 700 | 1 | _aWright, W E | |
| 700 | 1 | _aKuder, H V | |
| 773 | 0 |
_tApplied microbiology _gvol. 21 _gno. 3 _gp. 426-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/am.21.3.426-434.1971 _zAvailable from publisher's website |
| 999 |
_c4997443 _d4997443 |
||